Comparing smokers and non-smokers attending a rapid access lung cancer clinic

R. Roberts, K. Lewis (LLanelli, Swansea, United Kingdom)

Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Session: Three smoking-related diseases: cardiovascular, lung cancer and infection
Session type: Poster Discussion
Number: 327

Congress or journal article abstractE-poster

Abstract

Tobacco smoking is the biggest cause of lung cancer (LC) but continued smoking probably independently worsens outcomes.Aims:1. To assess the prevalence of smoking in people attending a rapid access clinic for suspected LC, given the changing demographics of UK smokers and introduction public smoking bans.2. To see if smoking status is associated with traditional adverse prognostic indicators for LC.As part of a larger trial we report on the first 415 attenders who were subsequently diagnosed with LC. Anyone who admitted to smoking within 7 days or who had an exhaled carbon monoxide >10 parts per million were deemed smokers. Patients also completed a baseline quality of life questionnaire (EQ5D) and WHO performance status.41% of attenders with LC were smoking at the time of their LC diagnosis.

Table to compare smokers and non-smokers (ex or never)
Variable Mean (SD)Non-smokers (N=244)Smokers (N=171)p-value
Age yrs69.4 (9.6)65.5 (10.0)0.005
TNM Stage3.12 (0.98)3.20 (0.92)0.496
Tumour staging2.45 (1.13)2.83 (1.20)0.024
WHO Performance Status1.00 (0.84)1.20 (0.89)0.026
Total EQ5D7.58 (2.19)7.91 (1.97)0.140

At the time of LC diagnosis current smokers were significantly younger yet had larger tumours and worse performance status. The larger tunour size may reflect delays in presentation or that nicotine accelerates tumour growth.1The lower performance status probably also reflects more co-morbidity (e.g. COPD/ cardiac dysfunction etc) as there was no significant difference in TNM cancer stage.Data collection continues to compare clinical outcomes and responses to treatment in smokers and non-smokers.1. Hecht, S.S. (1999). Tobacco smoke carcinogens and lung cancer. JNCI J Natl Cancer Inst,91 (14), 1194-1210.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Roberts, K. Lewis (LLanelli, Swansea, United Kingdom). Comparing smokers and non-smokers attending a rapid access lung cancer clinic. Eur Respir J 2014; 44: Suppl. 58, 327

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of cannabis and primary lung cancer
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014


Awareness of lung cancer symptoms and risk factors
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014


Evaluation of social nicotine dependence using the Kano test for social nicotine dependence (KTSND) questionnaire in patients with lung cancer
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014

Smoking habits of pre-surgery patients
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015


Short-term results of a registered smoking cessation clinic with patients referred by ALO 171 Quitline
Source: International Congress 2014 – Twenty views of smoking cessation and physical activity
Year: 2014


Investigation of smoking behaviours and the presence of COPD in a prison
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014


Higher incidence of lung cancer in female passive smokers
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

The influence of the UK national lung cancer campaign on fast-track referrals to secondary care
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013


Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Does smoking status after a diagnosis of lung cancer matter? Impact of quitting on 1 year survival
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015



Smoking habits and smoking behaviour of staff in Institutions for lung diseases and tuberculosis
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014


Evaluation of the effect of quit smoking with arteriosclerosis index in COPD patients
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014


Smoking cessation in patients with cancer under real life conditions
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


Smoking cessation in patients with asthma
Source: International Congress 2014 – Twenty views of smoking cessation and physical activity
Year: 2014


Smoking and lung cancer: Data from a single center in Greece
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015

Incidence of asthma as function of smoking habits in adults: An Italian follow-up study
Source: International Congress 2014 – Smoking and respiratory airway function and diseases
Year: 2014


Feasibility of smoking cessation services for patients with lung cancer; a patient centred approach
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

Are smoking cardiologists interest in smoking cessation?
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014


Early life tobacco smoke exposure is associated with asthma and lung function deficits in adolescents
Source: International Congress 2014 – Smoking and respiratory airway function and diseases
Year: 2014


Comparative study on lung cancer cannabis subjects, not cannabis
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015